<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04001335</url>
  </required_header>
  <id_info>
    <org_study_id>1298/19</org_study_id>
    <nct_id>NCT04001335</nct_id>
  </id_info>
  <brief_title>Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium</brief_title>
  <acronym>RapidLeish</acronym>
  <official_title>Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Tropical Medicine, Belgium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Tropical Medicine, Belgium</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cutaneous Leishmaniasis (CL) is a neglected tropical disease which is increasingly seen in&#xD;
      travelers and migrants evaluated in travel clinics of non-endemic countries. Various CL&#xD;
      species are present in different parts of the world, and these different species vary in&#xD;
      severity, prognosis and therapeutic approaches.&#xD;
&#xD;
      At ITM, diagnosis of CL in suspected patients is done using a skin biopsy, analyzed by&#xD;
      diagnostic PCR, and species typing PCR. This method is invasive, and diagnosis is often&#xD;
      delayed for days to weeks.&#xD;
&#xD;
      The new antigen-based CL Detect Rapid Test uses dental broach sampling and has results within&#xD;
      30 minutes. Dental broach samples left over from the Cl Detect Rapid test may still be used&#xD;
      for PCR including species typing.&#xD;
&#xD;
      How well the CL Detect Rapid Test performs in the varied population of a travel clinic and&#xD;
      whether it is possible to use dental broach sampling for further PCR tests in this population&#xD;
      needs to be evaluated The aim of this study is to study the performance of the CL Detect&#xD;
      Rapid Test and whether dental broach sampling can replace skin biopsy for CL at ITM.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No patient recruitment possible during COVID-19, inavailability RDTs&#xD;
  </why_stopped>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of CL detect RDT</measure>
    <time_frame>2019-2010</time_frame>
    <description>Against combined reference of microscopy and PCR using skin punch biopsy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of PCR positives on dental broach sample</measure>
    <time_frame>2019-2020</time_frame>
    <description>Compared to PCR positives on skin punch biopsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of successful species typing on dental broach sample</measure>
    <time_frame>2019-2020</time_frame>
    <description>Compared to successful species typing on skin punch biopsy sample</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6</enrollment>
  <condition>Cutaneous Leishmaniases</condition>
  <arm_group>
    <arm_group_label>CL suspicion</arm_group_label>
    <description>Patients with skin lesions suspected to be cutaneous leishmaniasis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dental Broach</intervention_name>
    <description>Dental broach, RDT and PCR</description>
    <arm_group_label>CL suspicion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspicion of CL will be screened for inclusion.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Skin biopsy for leishmania test requested by treating ITM clinician OR&#xD;
&#xD;
          -  externally requested skin biopsy for Leishmania tested at ITM with an ITM consultation&#xD;
             &lt;7 days of the biopsy sample&#xD;
&#xD;
          -  willing and able to provide consent/assent&#xD;
&#xD;
          -  not on CL treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saskia van Henten, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Tropical Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan van Griensven, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Tropical Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Tropical Medicine</name>
      <address>
        <city>Antwerp</city>
        <zip>2000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2019</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leishmaniasis</mesh_term>
    <mesh_term>Leishmaniasis, Cutaneous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

